Unknown

Dataset Information

0

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.


ABSTRACT: A substantial fraction of familial ovarian cancer cases cannot be attributed to specific genetic factors. The discovery of additional susceptibility genes will permit a more accurate assessment of hereditary cancer risk and allow for monitoring of predisposed women in order to intervene at the earliest possible stage. We focused on a population with elevated familial breast and ovarian cancer risk. In this study, we identified a SNP rs926103 whose minor allele is associated with predisposition to ovarian but not breast cancer in a Caucasian high-risk population without BRCA1/BRCA2 mutations. We have found that the allelic variation of rs926103, which alters amino acid 52 of the encoded protein SH2D2A/TSAd, results in differences in the activity of this protein involved in multiple signal transduction pathways, including regulation of immune response, tumor vascularization, cell growth, and differentiation. Our observation provides a novel candidate genetic biomarker of elevated ovarian cancer risk in members of high-risk families without BRCA1/2 mutations, as well as a potential therapeutic target, TSAd.

SUBMITTER: Kaplun L 

PROVIDER: S-EPMC3528110 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Variants in the Signaling Protein TSAd are Associated with Susceptibility to Ovarian Cancer in BRCA1/2 Negative High Risk Families.

Kaplun Ludmila L   Fridman Aviva Levine AL   Chen Wei W   Levin Nancy K NK   Ahsan Sidra S   Petrucelli Nancie N   Barrick Jennifer L JL   Gold Robin R   Land Susan S   Simon Michael S MS   Morris Robert T RT   Munkarah Adnan R AR   Tainsky Michael A MA  

Biomarker insights 20121212


A substantial fraction of familial ovarian cancer cases cannot be attributed to specific genetic factors. The discovery of additional susceptibility genes will permit a more accurate assessment of hereditary cancer risk and allow for monitoring of predisposed women in order to intervene at the earliest possible stage. We focused on a population with elevated familial breast and ovarian cancer risk. In this study, we identified a SNP rs926103 whose minor allele is associated with predisposition t  ...[more]

Similar Datasets

| S-EPMC3686592 | biostudies-literature
| S-EPMC5769462 | biostudies-literature
| S-EPMC3826381 | biostudies-other
2019-09-30 | GSE87080 | GEO
| S-EPMC4946366 | biostudies-literature
| S-EPMC5462348 | biostudies-literature
| S-EPMC3458423 | biostudies-literature
| S-EPMC6189145 | biostudies-literature
| S-EPMC3720732 | biostudies-literature
| S-EPMC5110056 | biostudies-literature